$RLAY
Relay Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$19.20
▲+1.29%+$0.245
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRelay Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RLAY up today? It is at $19.20 (+1.29%), and our scanner flagged it 161 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RLAY spikes, and full due diligence on RLAY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RLAY 161 times in the last 30 days. Create a free account to track $RLAY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
RLAY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on RLAY today, peaking at 12.2x its normal volume.
The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
11,310,571 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $213.0M in size · Priced at $18.83/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 8.5% | 520K | $913K at $18.94 | Sep 8, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 13% | 123K | $336K at $18.94 | Sep 8, 26 |
Bergstrom Donald A Officer | Sold (automatic/other) | -9K | sold 2.1% | 399K | $162K at $18.97 | Sep 8, 26 |
Rahmer Peter Officer | Sold (automatic/other) | -5K | sold 2.0% | 224K | $90K at $20.03 | Aug 26, 26 |
Svf Pauling (Cayman) Ltd Beneficial Owner (10%) | Sold (automatic/other) | -6.00M 2.7% of company | sold 22% | 21.90M | $116.4M at $19.40 | Aug 25, 26 |
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 7.8% | 568K | $980K at $20.33 | Aug 17, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 11% | 141K | $350K at $19.74 | Aug 14, 26 |
Bergstrom Donald A Officer | Sold (automatic/other) | -2K | sold 0.5% | 408K | $42K at $18.61 | Jul 28, 26 |
Rahmer Peter Officer | Sold (automatic/other) | -748 | sold 0.3% | 228K | $14K at $18.61 | Jul 28, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -1K | sold 0.9% | 158K | $27K at $18.61 | Jul 28, 26 |
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 7.3% | 616K | $944K at $19.58 | Jul 7, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 10.0% | 160K | $331K at $18.69 | Jul 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
RLAY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on RLAY today, peaking at 12.2x its normal volume.
RLAY last traded at $19.20, up 1.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Relay Therapeutics, Inc. Common Stock (RLAY) is next expected to report earnings on Thursday, November 5, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RLAY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLAY 161 times in the last 30 days.
RLAY (Relay Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $4.15B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLAY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RLAY discussion
Sign in to ask a question or join the discussion.